Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
europe blog main
europe top stories
life sciences
national blog main
san francisco blog main
san francisco top stories
abaloparatide
amgen
avapritinib
blueprint medicines
boston
boston blog main
boston top stories
cancer
cancer drugs
capmatinib
clinical trials
eli lilly
european commission
fda
gastrointestinal stromal tumors
genentech
indiana blog main
indiana top stories
life science
medullary thyroid cancer
national
national top stories
non-small cell lung cancer
novartis
osteoporosis
pralsetinib
radius health
roche
romosozumab
selpercatinib
teriparatide
thyroid cancer
ucb
What
approval
2
×
carries
2
×
drug
address
amgen
amgen’s
approves
blueprint
cancer
certain
designed
developed
europe
european
fda
genetic
heart
latest
marketing
medicine
medicines
nod
osteoporosis
pass
raise
ret
risk
signature
signatures
targeted
targeting
therapy
warning
wins
Language
unset
Current search:
carries
×
approval
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
